Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers from Erasmus University provide details of new studies and findings in the area of breast cancer
November 27th, 2008
According to a study from Rotterdam, Netherlands, "The purpose of the study was to compare early changes in blood flow (BF) and glucose metabolism (MRglu) in metastatic breast cancer lesions of patients treated with chemotherapy. Eleven women with stage IV cancer and lesions in breast, lymph nodes, liver, and bone were scanned before treatment and after the first course of chemotherapy." "BF, distribution volume of water (V-d), MRglu/BF ratio, MRglu and its corresponding rate constants K-1 and k(3) were compared per tumor lesion before and during therapy. At baseline, mean BF and MRglu varied among different tumor lesions, but mean V-d was comparable in all lesions....
Source: Women's Health Weekly (2008-11-27)
|
